AC Immune SA (ACIU)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 387.49M |
| Enterprise value | 272.26M |
| Trailing P/E | 11.63 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 20.77 |
| Price/book (mrq) | 2.37 |
| Enterprise value/revenue | 16.20 |
| Enterprise value/EBITDA | -0.76 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.27 |
| 52-week change 3 | 30.33% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 5.1400 |
| 52-week low 3 | 2.2000 |
| 50-day moving average 3 | 3.9169 |
| 200-day moving average 3 | 3.4182 |
Share statistics
| Avg vol (3-month) 3 | 872.21k |
| Avg vol (10-day) 3 | 231.13k |
| Shares outstanding 5 | 98.9M |
| Implied shares outstanding 6 | 103.16M |
| Float 8 | 41.93M |
| % held by insiders 1 | 41.87% |
| % held by institutions 1 | 29.94% |
| Shares short (15 Jul 2024) 4 | 964.93k |
| Short ratio (15 Jul 2024) 4 | 3.87 |
| Short % of float (15 Jul 2024) 4 | 1.82% |
| Short % of shares outstanding (15 Jul 2024) 4 | 0.98% |
| Shares short (prior month 14 Jun 2024) 4 | 801.37k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CHF.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -379.17% |
Management effectiveness
| Return on assets (ttm) | -20.85% |
| Return on equity (ttm) | -36.68% |
Income statement
| Revenue (ttm) | 14.8M |
| Revenue per share (ttm) | 0.17 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -54.5M |
| Net income avi to common (ttm) | -54.58M |
| Diluted EPS (ttm) | -0.6900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 104.82M |
| Total cash per share (mrq) | 1.05 |
| Total debt (mrq) | 3.33M |
| Total debt/equity (mrq) | 2.30% |
| Current ratio (mrq) | 7.78 |
| Book value per share (mrq) | 1.46 |
Cash flow statement
| Operating cash flow (ttm) | -42.58M |
| Levered free cash flow (ttm) | -24.21M |
© 2024 Yahoo. All rights reserved.